Luciferase reporter assays and rescue experiments demonstrated that miR-378a-3p inhibits hypoxia-induced EMT, invasion, and migration of osteosarcoma cells by targeting BYSL. Moreover, results of in vivo experiments further demonstrated that miR-378a-3p overexpression inhibits osteosarcoma cell proliferation. Here, BYSL is linked to osteosarcoma.